NASDAQ:ACOR
$0.502
(
-9.35%
)
Friday, 2nd Jun 2023
Acorda Therapeutics Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $0.470 | $1.21 | Friday, 2nd Jun 2023 ACOR stock ended at $0.502. This is 9.35% less than the trading day before Thursday, 1st Jun 2023. During the day the stock fluctuated 19.52% from a day low at $0.502 to a day high of $0.600. |
| 90 days | $0.449 | $1.21 | |
| 52 weeks | $0.261 | $1.24 |
Historical Acorda Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2023-06-02 | $0.550 | $0.600 | $0.502 | $0.502 | 292 153 |
| 2023-06-01 | $0.520 | $0.605 | $0.520 | $0.554 | 389 483 |
| 2023-05-31 | $0.610 | $0.640 | $0.600 | $0.600 | 54 349 |
| 2023-05-30 | $0.598 | $0.640 | $0.598 | $0.612 | 161 650 |
| 2023-05-26 | $0.597 | $0.650 | $0.582 | $0.595 | 182 697 |
| 2023-05-25 | $0.640 | $0.705 | $0.610 | $0.650 | 282 987 |
| 2023-05-24 | $0.673 | $0.680 | $0.640 | $0.645 | 205 770 |
| 2023-05-23 | $0.740 | $0.740 | $0.672 | $0.690 | 227 365 |
| 2023-05-22 | $0.770 | $0.770 | $0.677 | $0.725 | 238 536 |
| 2023-05-19 | $0.768 | $0.81 | $0.740 | $0.770 | 58 827 |
| 2023-05-18 | $0.768 | $0.81 | $0.714 | $0.780 | 303 588 |
| 2023-05-17 | $0.792 | $0.86 | $0.735 | $0.81 | 505 141 |
| 2023-05-16 | $0.627 | $0.80 | $0.614 | $0.800 | 514 501 |
| 2023-05-15 | $0.680 | $0.680 | $0.600 | $0.629 | 342 699 |
| 2023-05-12 | $0.84 | $0.88 | $0.690 | $0.695 | 1 035 462 |
| 2023-05-11 | $0.796 | $0.85 | $0.780 | $0.84 | 451 896 |
| 2023-05-10 | $0.86 | $0.92 | $0.751 | $0.85 | 1 400 052 |
| 2023-05-09 | $0.777 | $0.95 | $0.681 | $0.88 | 3 339 469 |
| 2023-05-08 | $0.560 | $1.21 | $0.520 | $0.88 | 40 396 163 |
| 2023-05-05 | $0.490 | $0.495 | $0.470 | $0.495 | 21 864 |
| 2023-05-04 | $0.500 | $0.500 | $0.470 | $0.470 | 41 359 |
| 2023-05-03 | $0.500 | $0.500 | $0.475 | $0.490 | 55 631 |
| 2023-05-02 | $0.480 | $0.490 | $0.470 | $0.470 | 19 564 |
| 2023-05-01 | $0.449 | $0.490 | $0.449 | $0.474 | 18 389 |
| 2023-04-28 | $0.488 | $0.490 | $0.460 | $0.465 | 36 312 |
| 2023-04-27 | $0.455 | $0.480 | $0.453 | $0.472 | 27 916 |
| 2023-04-26 | $0.480 | $0.490 | $0.450 | $0.451 | 25 873 |
| 2023-04-25 | $0.472 | $0.510 | $0.450 | $0.450 | 56 980 |
| 2023-04-24 | $0.490 | $0.526 | $0.470 | $0.470 | 61 789 |
| 2023-04-21 | $0.495 | $0.508 | $0.490 | $0.490 | 11 840 |
| 2023-04-20 | $0.510 | $0.530 | $0.484 | $0.484 | 55 249 |
| 2023-04-19 | $0.550 | $0.550 | $0.510 | $0.540 | 38 346 |
| 2023-04-18 | $0.510 | $0.538 | $0.510 | $0.525 | 26 009 |
| 2023-04-17 | $0.535 | $0.560 | $0.510 | $0.516 | 57 236 |
| 2023-04-14 | $0.550 | $0.590 | $0.525 | $0.530 | 54 169 |
| 2023-04-13 | $0.530 | $0.579 | $0.530 | $0.543 | 41 042 |
| 2023-04-12 | $0.560 | $0.560 | $0.525 | $0.531 | 16 145 |
| 2023-04-11 | $0.540 | $0.561 | $0.521 | $0.550 | 51 939 |
| 2023-04-10 | $0.521 | $0.547 | $0.510 | $0.545 | 44 605 |
| 2023-04-06 | $0.510 | $0.550 | $0.510 | $0.540 | 37 285 |
| 2023-04-05 | $0.535 | $0.550 | $0.502 | $0.516 | 66 503 |
| 2023-04-04 | $0.551 | $0.565 | $0.540 | $0.556 | 79 582 |
| 2023-04-03 | $0.551 | $0.580 | $0.551 | $0.565 | 67 529 |
| 2023-03-31 | $0.600 | $0.600 | $0.560 | $0.586 | 74 292 |
| 2023-03-30 | $0.600 | $0.618 | $0.543 | $0.576 | 120 617 |
| 2023-03-29 | $0.590 | $0.625 | $0.560 | $0.600 | 138 716 |
| 2023-03-28 | $0.541 | $0.600 | $0.541 | $0.585 | 58 533 |
| 2023-03-27 | $0.550 | $0.599 | $0.540 | $0.572 | 87 384 |
| 2023-03-24 | $0.550 | $0.596 | $0.526 | $0.548 | 93 003 |
| 2023-03-23 | $0.600 | $0.623 | $0.570 | $0.570 | 82 238 |
About Acorda Therapeutics
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS p... ACOR Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
